ClinicalTrials.Veeva

Menu

The Physiological Effect of High Flow Oxygen Therapy

G

Guangzhou Medical University

Status

Unknown

Conditions

Non-invasive Positive Pressure Ventilation
High-flow Nasal Cannula
Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Treatments

Device: HFNC
Device: NPPV

Study type

Interventional

Funder types

Other

Identifiers

NCT04212182
GIRH-HFNC8306

Details and patient eligibility

About

Although non-invasive positive pressure ventilation (NPPV) shows the good curative effect of treating the patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD), some patients do not tolerate NPPV or do not benefit from it. High-flow nasal cannula (HFNC) is well tolerated and may be used to patients with AECOPD who are intolerant to NPPV treatment. This study is to evaluate the physiological effect of HFNC and compare it with NPPV.

Enrollment

10 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • AECOPD patients with acute hypercapnic respiratory failure

Exclusion criteria

  • other lung/pleural diseases or thoracic deformity
  • severe heart failure (New York Heart Association class IV), severe dysrhythmia
  • unstable angina, or malignant comorbidity
  • obesity (BMI ≥ 35 kg/m²)
  • severe obstructive sleep apnea syndrome

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

10 participants in 2 patient groups

HFNC group
Experimental group
Description:
AECOPD patients receive ventilation support via HFNC.
Treatment:
Device: HFNC
NPPV group
Active Comparator group
Description:
AECOPD patients receive ventilation support via NPPV.
Treatment:
Device: NPPV

Trial contacts and locations

1

Loading...

Central trial contact

Lili Guan, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems